For unrevealing molecular mechanisms of CU27 inhibiting liver CSC, we first obtained differential gene expression profiles of CU27‐treated HCC cells, followed by integrating our IPA data and published literatures, leading us to hypothesize c‐Myc transcriptional activity may be the major target of CU27. The gene discussed is MYC; the disease is hepatocellular carcinoma.